Lentigen Technology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lentigen Technology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11522
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lentigen Technology Inc (Lentigen), a subsidiary of Miltenyi Biotec GmbH, is a provider of gene delivery and expression technology solutions. The company provides clinical trial support in viral vector product development and clinical applications, among others. Its lentiviral vectors finds application in the T cell and hematopoietic stem cell transduction. Lentigen also offers contract manufacturing programs for the production of lentiviral vector products. The company works in partnership with other organizations for the lentiviral vector development and manufacturing. Lentigen is headquartered in Gaithersburg, Maryland, the US.

Lentigen Technology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lentigen Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 10
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 11
Asset Transactions 12
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 12
Acquisition 13
Lentigen Technology Acquires Living Pharma 13
Lentigen Technology Inc – Key Competitors 14
Lentigen Technology Inc – Key Employees 15
Lentigen Technology Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Product News 17
02/07/2018: CAR-T Cell Immunotherapy Clinical Trial Cancer Patient in Remission; First-in-the-World Cancer Treatment Shows Promise 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lentigen Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lentigen Technology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 10
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 11
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 12
Lentigen Technology Acquires Living Pharma 13
Lentigen Technology Inc, Key Competitors 14
Lentigen Technology Inc, Key Employees 15
Lentigen Technology Inc, Subsidiaries 16

List of Figures
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lentigen Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lentigen Technology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aviva Ltd.:企業の戦略・SWOT・財務情報
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AeroMaoz Ltd.:企業の戦略・SWOT・財務分析
    AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report Summary AeroMaoz Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Merz Aesthetics Inc:企業の戦略的SWOT分析
    Merz Aesthetics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kosmos Energy Ltd (KOS):企業の財務・戦略的SWOT分析
    Kosmos Energy Ltd (KOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Singulex Inc-医療機器分野:企業M&A・提携分析
    Summary Singulex Inc (Singulex) is a medical device company develops single molecule counting technology. The company provides Sgx clarity system, an in vitro diagnostics platform that provides high sensitivity next generation immunodiagnostics. Its proprietary SMC technology allows scientists and p …
  • Groupe SMCP S.A.S.:企業の戦略的SWOT分析
    Groupe SMCP S.A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Viesgo:電力:M&Aディール及び事業提携情報
    Summary Viesgo, formerly E.ON Espana SL is an energy company that generates, distributes and markets electric power and gas. The company operates coal-fired power plants, combined cycle plants, biomass plants, and hydraulic power stations. It also provides public and private charging stations for el …
  • Select Medical Holdings Corp (SEM):企業の財務・戦略的SWOT分析
    Summary Select Medical Holdings Corp (Select Medical) is a healthcare service provider that offers outpatient rehabilitation services. The center provides long-term acute care services such as complex infectious disease treatment, respiratory failure, medically complex treatment, neurology, pulmonar …
  • Allan Myers Inc:企業の戦略・SWOT・財務分析
    Allan Myers Inc - Strategy, SWOT and Corporate Finance Report Summary Allan Myers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • QHR Corporation:医療機器:M&Aディール及び事業提携情報
    Summary QHR Corporation (QHR), a subsidiary of Shoppers Drug Mart Inc. (SDMI), formerly known as QHR Technologies Inc., is a healthcare technology provider. It offers electronic medical records (EMR) for healthcare professionals including family physicians, medical specialists, and surgeons. The com …
  • A&E Medical Corp:医療機器:M&Aディール及び事業提携情報
    Summary A&E Medical Corp (A&E Medical), a subsidiary of Vance Street Capital LLC, is a medical device company that manufactures and distributes surgical equipment. The company offers products such as temporary cardiac pacing wires, sternotomy sutures, lluminated vein harvest retractors, electrosurgi …
  • Red Electrica de Espana SA (REE)-エネルギー分野:企業M&A・提携分析
    Summary Red Electrica de Espana, S.A. (REE), a subsidiary of Red Electrica Corporacion S A. is a power transmission company. The company is involved in electricity transmission and other related operations through its transmission network. It manages the high-voltage transmission grid and is also re …
  • Integrated BioTherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases. The company's products include polyclonal and monoclonal antibodies raised against various emerging pathogens, vaccines and therapeutics against bacteria, p …
  • Allinky Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • Harmony Gold Mining Co Ltd:企業の戦略・SWOT・財務情報
    Harmony Gold Mining Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Harmony Gold Mining Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Vector Group Ltd (VGR):企業の財務・戦略的SWOT分析
    Vector Group Ltd (VGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Phillips 66 Co (PSX)-石油・ガス分野:企業M&A・提携分析
    Summary Phillips 66 Company (Phillips 66) is a diversified energy manufacturing and logistics company. It gathers, processes, transports and markets natural gas and petroleum products such as gasoline, diesel, aviation fuel and lubricants, and transports, fractionates and markets natural gas liquids …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆